IGM Biosciences (IGMS) Competitors $6.90 -0.15 (-2.13%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IGMS vs. EVO, ARQT, NRIX, RCUS, KNSA, IMCR, OCUL, MESO, TVTX, and NTLAShould you be buying IGM Biosciences stock or one of its competitors? The main competitors of IGM Biosciences include Evotec (EVO), Arcutis Biotherapeutics (ARQT), Nurix Therapeutics (NRIX), Arcus Biosciences (RCUS), Kiniksa Pharmaceuticals (KNSA), Immunocore (IMCR), Ocular Therapeutix (OCUL), Mesoblast (MESO), Travere Therapeutics (TVTX), and Intellia Therapeutics (NTLA). These companies are all part of the "pharmaceutical products" industry. IGM Biosciences vs. Evotec Arcutis Biotherapeutics Nurix Therapeutics Arcus Biosciences Kiniksa Pharmaceuticals Immunocore Ocular Therapeutix Mesoblast Travere Therapeutics Intellia Therapeutics Evotec (NASDAQ:EVO) and IGM Biosciences (NASDAQ:IGMS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation. Does the MarketBeat Community believe in EVO or IGMS? IGM Biosciences received 66 more outperform votes than Evotec when rated by MarketBeat users. However, 54.55% of users gave Evotec an outperform vote while only 50.70% of users gave IGM Biosciences an outperform vote. CompanyUnderperformOutperformEvotecOutperform Votes654.55% Underperform Votes545.45% IGM BiosciencesOutperform Votes7250.70% Underperform Votes7049.30% Which has more volatility and risk, EVO or IGMS? Evotec has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, IGM Biosciences has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Is EVO or IGMS more profitable? Evotec has a net margin of 0.00% compared to IGM Biosciences' net margin of -7,534.03%. Evotec's return on equity of 0.00% beat IGM Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets EvotecN/A N/A N/A IGM Biosciences -7,534.03%-155.42%-61.04% Do analysts prefer EVO or IGMS? Evotec currently has a consensus target price of $5.93, suggesting a potential upside of 32.74%. IGM Biosciences has a consensus target price of $17.75, suggesting a potential upside of 157.25%. Given IGM Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe IGM Biosciences is more favorable than Evotec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evotec 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20IGM Biosciences 1 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better valuation & earnings, EVO or IGMS? Evotec has higher revenue and earnings than IGM Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvotec$777.05M2.04-$90.82MN/AN/AIGM Biosciences$2.92M140.61-$246.42M-$3.64-1.90 Do institutionals and insiders hold more shares of EVO or IGMS? 5.8% of Evotec shares are held by institutional investors. Comparatively, 42.8% of IGM Biosciences shares are held by institutional investors. 1.0% of Evotec shares are held by company insiders. Comparatively, 57.0% of IGM Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer EVO or IGMS? In the previous week, IGM Biosciences had 3 more articles in the media than Evotec. MarketBeat recorded 6 mentions for IGM Biosciences and 3 mentions for Evotec. Evotec's average media sentiment score of 1.57 beat IGM Biosciences' score of 0.35 indicating that Evotec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evotec 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive IGM Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryEvotec and IGM Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGMS vs. The Competition Export to ExcelMetricIGM BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$410.30M$6.57B$5.02B$9.08BDividend YieldN/A3.09%4.87%4.20%P/E Ratio-1.9010.55135.0817.16Price / Sales140.61194.011,120.30115.67Price / CashN/A57.1640.5837.88Price / Book1.995.104.754.78Net Income-$246.42M$151.51M$118.50M$225.60M7 Day Performance-3.77%-2.13%-1.85%-1.21%1 Month Performance-22.38%-3.13%11.28%3.09%1 Year Performance-20.05%11.54%29.91%16.48% IGM Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGMSIGM Biosciences4.5517 of 5 stars$6.90-2.1%$17.75+157.2%-12.2%$410.30M$2.92M-1.90190News CoverageGap DownEVOEvotec2.3819 of 5 stars$4.67+4.0%$5.93+27.1%-60.5%$1.65B$777.05M0.005,061Positive NewsARQTArcutis Biotherapeutics0.8585 of 5 stars$13.19+3.9%$15.50+17.5%+478.8%$1.54B$138.71M-7.58150Options VolumeNRIXNurix Therapeutics2.507 of 5 stars$21.15+4.3%$30.35+43.5%+101.7%$1.50B$56.42M-6.97300News CoverageRCUSArcus Biosciences2.6571 of 5 stars$16.22+0.9%$34.00+109.6%-9.3%$1.48B$117M-5.11500News CoverageGap DownKNSAKiniksa Pharmaceuticals2.5294 of 5 stars$20.36+0.8%$36.60+79.8%+15.4%$1.47B$384.10M-147.36220Positive NewsIMCRImmunocore2.4978 of 5 stars$29.15+0.8%$65.64+125.2%-51.4%$1.46B$296.31M-30.43497Short Interest ↓OCULOcular Therapeutix3.6461 of 5 stars$9.03+3.9%$16.71+85.1%+116.8%$1.42B$58.44M0.00267Positive NewsMESOMesoblast1.0474 of 5 stars$12.16+3.4%$11.50-5.4%+590.1%$1.39B$5.90M0.0080Analyst ForecastOptions VolumeNews CoverageGap DownTVTXTravere Therapeutics2.7815 of 5 stars$17.65+1.9%$22.62+28.1%+106.0%$1.38B$145.24M-3.81460Positive NewsNTLAIntellia Therapeutics4.1186 of 5 stars$13.50+4.7%$54.94+306.9%-58.9%$1.37B$36.28M-2.37600 Related Companies and Tools Related Companies EVO Alternatives ARQT Alternatives NRIX Alternatives RCUS Alternatives KNSA Alternatives IMCR Alternatives OCUL Alternatives MESO Alternatives TVTX Alternatives NTLA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IGMS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IGMS Stock Alerts